BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,789,000 | -16.1% | 2,500,000 | -16.7% | 0.01% | -20.0% |
| Q2 2017 | $3,324,000 | -26.9% | 3,000,000 | -25.0% | 0.02% | -28.6% |
| Q1 2017 | $4,550,000 | +61.3% | 4,000,000 | +60.0% | 0.02% | +50.0% |
| Q4 2016 | $2,820,000 | – | 2,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MACKAY SHIELDS LLC | 25,176,000 | $27,679,000 | 1.40% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,155,000 | $40,718,000 | 0.64% |
| OAKTREE CAPITAL MANAGEMENT LP | 24,250,000 | $26,747,000 | 0.50% |
| Jabre Capital Partners S.A. | 3,500,000 | $3,838,000 | 0.37% |
| Calamos Advisors LLC | 40,441,000 | $44,067,000 | 0.28% |
| Calamos Wealth Management LLC | 669,000 | $729,000 | 0.22% |
| Baker Brothers Advisors | 12,500,000 | $13,699,000 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,024,000 | $5,508,000 | 0.14% |
| SSI INVESTMENT MANAGEMENT LLC | 1,127,000 | $1,236,000 | 0.13% |
| Compagnie Lombard Odier SCmA | 1,300,000 | $1,423,000 | 0.06% |